Correlation Between Salesforce and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Salesforce and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Genmab AS, you can compare the effects of market volatilities on Salesforce and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Genmab AS.
Diversification Opportunities for Salesforce and Genmab AS
-0.9 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Genmab is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Salesforce i.e., Salesforce and Genmab AS go up and down completely randomly.
Pair Corralation between Salesforce and Genmab AS
Considering the 90-day investment horizon Salesforce is expected to generate 1.28 times more return on investment than Genmab AS. However, Salesforce is 1.28 times more volatile than Genmab AS. It trades about 0.21 of its potential returns per unit of risk. Genmab AS is currently generating about -0.21 per unit of risk. If you would invest 29,889 in Salesforce on August 30, 2024 and sell it today you would earn a total of 3,112 from holding Salesforce or generate 10.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Genmab AS
Performance |
| Timeline |
| Salesforce |
| Genmab AS |
Salesforce and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Genmab AS
The main advantage of trading using opposite Salesforce and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. BeiGene | Genmab AS vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |